| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/11/2000 | US6048895 Antagonists of prostaglandin f for treating bone fractures and diseases and glaucoma |
| 04/11/2000 | US6048880 Therapy for cytokine sensitive diseases |
| 04/11/2000 | US6048553 Aqueous metal bicarbonate solution useful in treating inflammatory, degenerative and viral diseases |
| 04/08/2000 | CA2285120A1 Heterocycles |
| 04/06/2000 | WO2000019206A1 Ykl-40 as a marker and prognostic indicator for cancers |
| 04/06/2000 | WO2000018954A2 Use of pex in the treatment of metabolic bone diseases |
| 04/06/2000 | WO2000018932A2 Receptor based antagonists and methods of making and using |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018799A1 Artemin, a novel neurotrophic factor |
| 04/06/2000 | WO2000018794A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 04/06/2000 | WO2000018760A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |
| 04/06/2000 | WO2000018759A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 04/06/2000 | WO2000018747A1 Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
| 04/06/2000 | WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors |
| 04/06/2000 | WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/06/2000 | WO2000018437A1 Tie2 antagonist antibodies |
| 04/06/2000 | WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | WO2000018230A1 Combination of bisphosphonate and tetracycline |
| 04/06/2000 | WO1999062505A3 Method for treating neurodegenerative disorders |
| 04/06/2000 | WO1999059608A3 Osteoporosis treatment |
| 04/06/2000 | CA2794705A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 04/06/2000 | CA2345641A1 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
| 04/06/2000 | CA2343972A1 Ykl-40 as a marker and prognostic indicator for cancers |
| 04/06/2000 | CA2343929A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 04/06/2000 | CA2343927A1 Artemin, a novel neurotrophic factor |
| 04/06/2000 | CA2343098A1 Combination of bisphosphonate and tetracycline |
| 04/06/2000 | CA2340454A1 Benzamide derivatives and their use as cytokine derivatives |
| 04/06/2000 | CA2338442A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 04/06/2000 | CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/05/2000 | EP0990031A2 Tumor necrosis factor receptor 5 |
| 04/05/2000 | EP0990000A1 Connective tissue growth factor-3 |
| 04/05/2000 | EP0989993A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 04/05/2000 | EP0989985A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 04/05/2000 | EP0989982A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 04/05/2000 | EP0989975A1 Oxazole compounds useful as pge2 agonists and antagonists |
| 04/05/2000 | EP0989973A1 Chalcones having antiproliferative activity |
| 04/05/2000 | CN1249745A Vitronectin receptor antagonists |
| 04/05/2000 | CN1249744A Nitric oxide synthase inhibitors |
| 04/05/2000 | CN1249743A Arylsulfonylamino hydroxamic acid derivs |
| 04/05/2000 | CN1249689A Stable solid preparation contg. vitamin D3 and tricalcium phosphate |
| 04/05/2000 | CN1249192A Chinese medicine for treating gout |
| 04/05/2000 | CN1249181A Universal medicinal cream and its preparing process |
| 04/04/2000 | US6046314 Spα: a novel scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto |
| 04/04/2000 | US6046232 α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same |
| 04/04/2000 | US6046204 Treatment of immunosuppressive, autoimmune, inflammatory, proliferative and hyperproliferative diseases including cancer, and of cutaneous manifestations of immunologically mediated diseases, for example rheumatoid arthritis, lupus |
| 04/04/2000 | US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 04/04/2000 | US6046162 Suppression of cell proliferation by decorin |
| 04/04/2000 | US6046049 Compound 8 to 30 nucleobases in length targeted to 3' untranslated region of nucleic acid which encodes human phosphatidyl inositol 3' kinase p110 delta isoform found in leukocytes; diagnosis, treatment of related diseases |
| 04/04/2000 | US6045792 Human proteins kinases |
| 03/30/2000 | WO2000017392A1 Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | WO2000017354A1 Human isre-binding protein |
| 03/30/2000 | WO2000017222A1 31 human secreted proteins |
| 03/30/2000 | WO2000017204A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 03/30/2000 | WO2000017192A1 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 03/30/2000 | WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 03/30/2000 | WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/30/2000 | WO2000017175A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/30/2000 | WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 03/30/2000 | WO2000017162A1 Novel thiol derivatives, process for producing the same and utilization thereof |
| 03/30/2000 | WO2000017133A2 Lta4 hydrolase inhibitors |
| 03/30/2000 | WO2000016781A1 Chk1 kinase inhibitors |
| 03/30/2000 | WO2000016772A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 03/30/2000 | WO2000016767A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 03/30/2000 | WO2000009096B1 Injectable formulations of nanoparticulate naproxen |
| 03/30/2000 | WO2000008196A3 Urate oxidase |
| 03/30/2000 | WO1999066918A9 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 03/30/2000 | WO1999065449A3 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 03/30/2000 | WO1999060127A9 Il-17 homologous polypeptides and therapeutic uses thereof |
| 03/30/2000 | WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 03/30/2000 | DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments |
| 03/30/2000 | DE19842833A1 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung 2-arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole and 2-Arylalkinylthio-imidazoles as inflammatory inhibitors and inhibitors of cytokine release |
| 03/30/2000 | CA2344657A1 Human isre-binding protein |
| 03/30/2000 | CA2344412A1 Thiol compound, their production and use |
| 03/30/2000 | CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 03/30/2000 | CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/30/2000 | CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 03/30/2000 | CA2344100A1 31 human secreted proteins |
| 03/30/2000 | CA2343360A1 Human cytoskeleton associated proteins |
| 03/30/2000 | CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/30/2000 | CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 03/29/2000 | EP0988379A1 Ldl-receptor |
| 03/29/2000 | EP0988374A1 Hydrophilic composition containing protease produced by vibrio |
| 03/29/2000 | EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 03/29/2000 | EP0988301A1 Imidazolyl-cyclic acetals |
| 03/29/2000 | EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines |
| 03/29/2000 | EP0988043A1 Method and product using sturgeon notochord for alleviating the symptoms of arthritis |
| 03/29/2000 | EP0988038A1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 03/29/2000 | EP0988035A1 Caspases and apoptosis |
| 03/29/2000 | EP0726763B1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| 03/29/2000 | CN1248966A Aminobenzophenones as inhibitors of interleukin and TNF |
| 03/29/2000 | CN1248448A Scorption and ant health care liquor |
| 03/29/2000 | CN1248443A Quick-acting traditional Chinese medicinal preparation for fracture setting |